In Brief
This article was originally published in The Rose Sheet
Executive Summary
Inter Parfums’ “ambitious” launch schedule in 2011 pays off as firm’s sales jumped 34% to $615.2 mil., marking best year in firm’s history, according to Chairman and CEO Jean Madar. More news in brief.
You may also be interested in...
Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims
Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.
Is 'Moisturol' Up For Grabs? NBC's Faux Nutricosmetic May Be Worth Reconsidering
The "Moisturol" pill that Dateline NBC pitched in 2006 to test the integrity of the infomercial industry – because it "could not possibly work as advertised" – is a lot less outrageous today amid a global nutricosmetics boom. The Rose Sheet considers how the faux beauty-from-within innovation might fare with consumers and regulators in 2017.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.